𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Analysis of the results of the micronucleus test in patients presenting upper digestive tract cancers and in non-cancerous subjects

✍ Scribed by A. M. Mandard; F. Duigou; J. Marnay; Ph.-Masson; Qiu-Song-Lang; Yi-Jing-Shu; P. Barrellier; G. Lebigot


Publisher
John Wiley and Sons
Year
1987
Tongue
French
Weight
338 KB
Volume
39
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


A micronucleus test was performed on 75 subjects of whom 38 presented with cancer of the upper digestive tract and 37 were free of disease; the absence of cancerous or pre-cancerous lesions in this latter group was confirmed by endoscopy and vital staining. The daily levels of alcohol and tobacco consumption of the 75 subjects were determined by precise questioning: 78% of the non-cancerous subjects smoked less than 10 g of tobacco per day whereas 19% of the cancer patients smoked 10 g or more daily. The alcohol intake of 78% of the non-cancerous subjects and 63% of the cancer patients was less than 101 ml per day. Only IOYO of the cancer patients had combined daily intake levels corresponding to the threshold of sensitivity of the micronucleus test as defined by previous studies. The mean frequency of micronucleated buccal cells was 0.26% in the cancer patients and 0.13% in the noncancerous subjects. All non-cancerous patients presented a negative test. Only 5 % of the cancer patients presented a micronucleated cell frequency above IYo and could thus be considered as positive. I t thus appears that the micronucleus test was not significantly positive in our population of 38 cancer patients.


πŸ“œ SIMILAR VOLUMES


Aberrant FHIT transcripts in cancerous a
✍ Yi-Jen Chen; Pao-Huei Chen; Meng-Dar Lee; Jan-Gowth Chang πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 119 KB πŸ‘ 2 views

The FHIT gene was recently discovered and proposed as a tumor-suppressor gene. We examined the FHIT gene in a panel of digestive-tract cancers along with their corresponding non-tumorous tissues by reverse transcription of FHIT mRNA followed by PCR amplification and sequencing of the products. A nor

Occurrence of non-gastric cancer in the
✍ Anne C. Tersmette; Johan G. A. Offerhaus; Francis M. Giardiello; W. F. Kasper Te πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 French βš– 457 KB πŸ‘ 1 views

## Abstract If peptic ulcer surgery favors the formation of carcinogenic N‐nitroso compounds in the gastric remnant, an increased risk of cancer at sites in the gastrointestinal tract distant from the stomach might be predicted. To estimate the risk of carcinomas in the digestive tract, other than

Association of polymorphisms in the cycl
✍ Shama Buch; Bing Zhu; Autumn Gaither Davis; Dominic Odom; Jill M. Siegfried; Jen πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 109 KB

## Abstract DNA repair enzyme genetic polymorphisms have been postulated to increase the risk of certain cancers in the presence of tobacco carcinogen exposures. The XPD protein is an important component of the TFIIH transcription factor complex. __XPD__ genetic polymorphisms resulting in amino aci

Lifetime and baseline alcohol intake and
✍ Cornelia Weikert; Thomas Dietrich; Heiner Boeing; Manuela M. Bergmann; Marie Chr πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 97 KB πŸ‘ 1 views

## Abstract Recent alcohol consumption is an established risk factor for squamous cell carcinoma (SCC) of the upper aero‐digestive tract. In contrast, the role of lifetime exposure to alcohol with regard to risk of SCC is not well established. Historical data on alcohol use are available in 271,253

Results of a pilot study of the effects
✍ Victor Lai; Jonathan George; Luther Richey; Hong J. Kim; Trinitia Cannon; Carol πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 144 KB πŸ‘ 2 views

## Abstract ## Background. Animal models suggest that cyclooxygenase‐2 (COX‐2) inhibitors may be beneficial in suppressing cancer cachexia. We investigated the effect of short‐course celecoxib on body composition, inflammation, and quality of life (QOL) in patients with cancer cachexia in a phase